@EdwardHughes:Today, we take our first in-depth look at Rubius Therapeutics which has developed a new class of cellular therapies called Red Cell Therapeutics.The company's pipeline has several candidates in development and Rubius recently addressed its current funding needs.A full investment analysis follows in the paragraphs below.

@Lewis Foong:Hi tigers family,  I was joining tiger few months before, therefore I am very awareness investor although I had 2 years experience in Malaysia share market despite stills losing money. I mostly all in all my saving in Malaysia stocks because i was immature and joined and listened some Guru talk which always took you riding merry go round in theirs talk( bull shit talk) , past is past, I  felt down and i stood up with resetting mind, mood, gathering past failure experience restarting my investment long trip in tiger again! What I did ? I started collecting ticket in qqqm because i have not enough bullet invest in many of many favorites counter,and believe no so much time to review too many company reports in once, believe some of tigers seem to be like me,